Article
HIV Replication Under High-Level Cabotegravir Is Associated with the Appearance of 3'-PPT Mutations, Circular DNA Transcription and Recombination.
Viruses - 30 Nov 2024
Wei Xierong, Lipscomb Jonathan T, Tino Ariana Santos, Cong Mian-Er, Ruone Susan, Bentz Meghan L, Sheth Mili, Garcia-Lerma Gerardo, Johnson Jeffrey A
Abstract excerpt
The HIV integrase inhibitor, dolutegravir (DTG), in the absence of eliciting integrase (int) resistance, has been reported to select mutations in the virus 3'-polypurine tract (3'-PPT) adjacent to the 3'-LTR U3. An analog of DTG, cabotegravir (CAB), has a high genetic barrier to drug resistance and is used in formulations for treatment and long-acting pre-exposure prophylaxis. We examined whether mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
